Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure



Status:Completed
Conditions:Atrial Fibrillation, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:65 - Any
Updated:1/6/2019
Start Date:November 30, 2017
End Date:November 8, 2018

Use our guide to learn which trials are right for you!

Real-World Comparative Effectiveness Research Among Elderly Non-valvular Atrial Fibrillation (NVAF) Patients With Heart Failure (HF) Using Oral Anticoagulants

Observational study of elderly individuals diagnosed with Non-Valvular Atrial Fibrillation
and Heart Failure who are beginning oral blood thinners


Inclusion Criteria:

- Were age greater than or equal to 65 years as of the index date

- Had greater than or equal to 1 diagnosis of AF prior to or on the index date

- Had greater than or equal to 1 diagnosis claim of HF during the 12 months prior to or
on the index date

- Had 1 or more pharmacy claim for oral blood thinners

Exclusion Criteria:

- Claims indicating diagnosis or procedure for hip/knee replacement surgery within 6
weeks prior to index date

- Pharmacy claim for warfarin, apixaban, dabigatran, edoxaban or rivaroxaban during the
12-month baseline period

- Greater than 1 oral anticoagulants prescription claim on the index date and/or with a
follow-up less than 1 day

- Had medical claim indicating VTE in the 12 months prior to index date

Other protocol defined inclusion/exclusion criteria could apply
We found this trial at
1
site
Ann Arbor, Michigan 48109
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials